目的 探討護理行為對重癥急性胰腺炎患者在實時強化血糖控制和治療中的效果與影響。 方法 選擇2010年7月－2011年7月15例采用強化血糖控制研究的急性重癥胰腺炎患者，對其實時24 h動態血糖監測的護理方法及要點進行回顧分析。 結果 15例患者順利完成強化血糖控制的臨床研究，血糖值達到目標監測范圍（6.1～8.3 mmol/L）的百分比例78.3%，未出現嚴重并發癥。 結論 實時動態的血糖監測、嚴格執行的強化血糖控制方案及針對性護理措施可為重癥胰腺炎患者的血糖強化控制提供安全有效的保證。
In recent years, China’s healthcare system reform has been continuously deepening, with third-party medical laboratories gradually transitioning from a “supplementary role” to an important component of the healthcare service system. With the introduction of regulations such as the “Basic Standards and Management Specifications for Medical Laboratories”, the requirements for industry access and operational standardization have been clarified, and increasing attention has been paid to compliance issues in the medical laboratory industry. This article systematically outlines the regulatory framework for domestic third-party medical laboratories, covering key aspects such as administrative approvals, quality management, cost control, and industry supervision. It aims to provide actionable guidance for practitioners, and promote the compliant operation and service quality improvement of third-party medical laboratories.